MedTrace Logo

Clinical Evaluation of RFAL of Breast Envelope and NAC Position

NCT03863834 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2022-08-16

Study results available
· View outcomes & findings →

Summary

This single center clinical study is intended to determine the safety and efficacy of using Radiofrequency (RF) energy for minimally invasive breast lift procedure.

Conditions

  • Breast Lift

Interventions

DEVICE

InModeRF

InModeRF minimally invasive treatment based on Radiofrequency-assisted lipolysis (RFAL) technology

Sponsors & Collaborators

  • InMode MD Ltd.

    lead INDUSTRY

Principal Investigators

  • Jacob Unger, MD · Maxwell Aesthetics 2020 21st Ave, South, Nashville, TN, 37212, USA

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-13
Primary Completion
2020-04-01
Completion
2020-04-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03863834 on ClinicalTrials.gov